The UvA-LINKER will give you a range of other options to find the full text of a publication (including a direct link to the full-text if it is located on another database on the internet).
De UvA-LINKER biedt mogelijkheden om een publicatie elders te vinden (inclusief een directe link naar de publicatie online als deze beschikbaar is in een database op het internet).


Zoekopdracht: journal id: "aids"

AuteursR.F.A. L'homme, H.M.J. Nijland, L. Gras, R.E. Aarnoutse, R. van Crevel, M. Boeree, K. Brinkman, J.M. Prins, J.R. Juttmann, D.M. Burger
TitelClinical experience with the combined use of lopinavir/ritonavir and rifampicin
SamenvattingThirty-four patients treated concomitantly with lopinavir/ritonavir and rifampicin were evaluated. Overall, only 15% used the recommended increased dose of lopinavir/ritonavir. Of patients on a nonadjusted dose of lopinavir/ritonavir, 67% had a subtherapeutic lopinavir plasma concentration and 38% had a detectable viral load. Forty percent of patients on an increased dose of lopinavir/ritonavir prematurely stopped the drug combination because of adverse events. Combined use of lopinavir/ritonavir and rifampicin is challenging as it implies balancing between suboptimal efficacy and toxicity
Soort documentArtikel
Document finderUvA-Linker